NCT04594174

Brief Summary

Fluid therapy is considered a first-line therapy in resuscitation protocols for hemodynamically unstable patients. The administration of fluids usually translates into an increase in Cardiac Output. However, not all patients increase mean blood pressure after fluid administration. To determine if fluids the administration improves blood pressure, it is necessary to evaluate the dependence of preload, vasomotor tone, and left ventricular stroke volume. The aim of this study is to confirm the usefulness of dynamic elastance, cardiovascular impedance, cardiac cycle efficiency, and other hemodynamic parameters calculated with the PRAM method as predictors of blood pressure response after fluid administration in open abdominal surgery. This will allow us to make and evaluate a predictive model for the blood pressure response after fluid administration in open abdominal surgery.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
320

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2020

Typical duration for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 5, 2020

Completed
15 days until next milestone

First Posted

Study publicly available on registry

October 20, 2020

Completed
12 days until next milestone

Study Start

First participant enrolled

November 1, 2020

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2020

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
Last Updated

October 22, 2020

Status Verified

October 1, 2020

Enrollment Period

Same day

First QC Date

October 5, 2020

Last Update Submit

October 20, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Dynamic elastacy ratio PPV/SVV

    PPV/SVV

    During surgery

Study Arms (2)

Responders

Procedure: Fluid administration

Non responders

Procedure: Fluid administration

Interventions

Patients will be treated in accordance with the criteria of the responsible physician and the hemodynamic data obtained with the Mostcareup monitor will be recorded and used for decision-making according to the hemodynamic management protocols of each center. If the patient has a PPV ≥ 14%, for 3 minutes and a MAP \<65 mm Hg or a Systolic Blood Pressure \<90 mm Hg, a bolus volume load of 3 ml / kg weight of a balanced crystalloid solution in a time of 10 minutes36,37. The start of the volume charge (T1) will be noted by an event mark on the MostCareup monitor. The end of the volume charge (T2) will be noted by an event mark on the MostCareup monitor. Five minutes after the completion of the volume charge a new event will be marked on the MostCare monitor (T3). Both brands will serve as a reference for the analysis of hemodynamic data. Patients will be considered responders to the administration of fluids if the cardiac index (CI) increase.

Non respondersResponders

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients scheduled for open abdominal surgery, older than 18 years. All sex participates and not gender based.

You may qualify if:

  • Patients ≥ 18 years
  • Patients scheduled for open abdominal surgery lasting ≥ 120 minutes under general anesthesia with mechanical ventilation and the use of VT of 8 ml / kg ideal weight and who require serious arterial monitoring.

You may not qualify if:

  • Patients \<18 years.
  • Patients\> 80 years.
  • Pregnant women.
  • Urgent surgery.
  • ASA \>3
  • Pathologies that may alter the quality of the arterial signal due to alterations of the dicrotic incisura.
  • Poor quality of the arterial pressure wave due to artifacts of the transduction system (resonance and damping).
  • Personal history of:
  • Cardiac arrhythmia.
  • Left ventricular ejection fraction \<30%
  • Right ventricular dysfunction (peak systolic tricuspid annulus velocity \<0.16 m / sec)
  • Intracardiac shunt
  • Preoperative creatinine\> 1.4 mg / dl.
  • Dialysis
  • Previous treatment with beta-blockers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Hypodermoclysis

Intervention Hierarchy (Ancestors)

Infusions, SubcutaneousInfusions, ParenteralDrug Administration RoutesDrug TherapyTherapeuticsFluid Therapy

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthetist

Study Record Dates

First Submitted

October 5, 2020

First Posted

October 20, 2020

Study Start

November 1, 2020

Primary Completion

November 1, 2020

Study Completion

November 1, 2023

Last Updated

October 22, 2020

Record last verified: 2020-10